Management of hot flushes in breast cancer patients.
In breast cancer patients, menopausal symptoms such as hot flushes can be a bothersome problem, with a significant impact on quality of life. Hormone replacement therapy, the mainstay for treatment of these symptoms in healthy women, is traditionally contraindicated. There are, however, several other strategies for the management of flushes in breast cancer patients and these are reviewed in this article.
Department of Internal Medicine, Division of Medical Oncology, University Hospital Groningen, P.O. Box 30.001, NL-9700 RB Groningen, The Netherlands. a.n.m.wymenga@int.azg.nl
A N Machteld
AN
Wymenga
Dirk T
DT
Sleijfer
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000503:physiopathology*; D003511:Cyclohexanols / Q000627:therapeutic use; D005260:Female; D019584:Hot Flashes / Q000628:therapy*; D006801:Humans; D019290:Megestrol Acetate / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D000316:Adrenergic alpha-Agonists; D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride; D019290:Megestrol Acetate